Libenzapril (Abutapril, CGS-16617) is an orally active, potent direct-acting angiotensin-converting-enzyme (ACE) inhibitor. Libenzapril has the potential for ischemia-induced heart failure research[1].
Molecular Weight:
363.41
CAS Number:
[109214-55-3]
Formula:
C18H25N3O5
Target:
Angiotensin-converting Enzyme (ACE)
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted